Pricing Log in Create free account

ADC Therapeutics SA (ADCT) vs Glass House Brands Inc. (GLAS)

ADC Therapeutics SA and Glass House Brands Inc. are both Drug Manufacturers Specialty & Generic companies. ADC Therapeutics SA is the larger, with a market value of $209.4M against $172.7M — 1.2× the size. ADC Therapeutics SA grew revenue faster over the last twelve months: 3.03% against −15.4%. Glass House Brands Inc. has the higher net margin (−36.2% vs −121.8%) and the lower return on invested capital (−23.4% vs 0.00%). Across the 16 metrics below, Glass House Brands Inc. leads on 9 and ADC Therapeutics SA on 7.

Valuation

Metric ADCT GLAS Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 3.23 1.14 2.08
P/B n/m 2.79 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 1.95 1.35 2.87
Earnings yield (39.76%) (33.33%) (15.94%)
Free cash flow yield (39.53%) (18.18%) 0.00%

Profitability

Metric ADCT GLAS Drug Manufacturers Specialty & Generic median
Gross margin 88.86% 31.97% 53.51%
Operating margin (125.08%) (23.18%) 0.00%
Net margin (121.77%) (36.19%) (2.45%)
Free cash flow margin (127.72%) (20.78%) 0.00%
Return on equity 45.35% (74.02%) (0.80%)
Return on assets (32.25%) (19.78%) (1.67%)
Return on invested capital 0.00% (23.36%) 0.00%

Growth

Metric ADCT GLAS Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 3.03% (15.38%) 5.22%
EPS growth (last fiscal year) 30.86% (161.90%) 42.91%
Revenue growth, 5-year CAGR 103.35% — 7.24%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ADCT GLAS Drug Manufacturers Specialty & Generic median
Debt to equity (0.51) 0.77 0.04
Current ratio 3.03 1.33 2.41
Net debt to EBITDA 1.22 (64.84) 1.01

Dividend

Metric ADCT GLAS Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric ADCT GLAS Drug Manufacturers Specialty & Generic median
Market cap 209.38m 172.67m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack